Neurocrine Bioscienc (NBIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NBIX | TAK | ZTS | GRFS | IONS |
| Company | Neurocrine Bioscienc | Takeda Pharmaceutical Ltd ADR | Zoetis Inc Cl A | Grifols S.A. ADR | Ionis Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 120.28 | 14.85 | 192.94 | 8.97 | 42.70 |
| High | 120.28 | 14.87 | 194.55 | 9.12 | 43.11 |
| Low | 117.00 | 14.76 | 191.07 | 8.94 | 42.37 |
| Last | 118.35 | 14.80 | 192.64 | 8.95 | 42.76 |
| Change | -2.11 | -0.13 | -0.60 | -0.13 | +0.02 |
| % Change | -1.75% | -0.87% | -0.31% | -1.43% | +0.05% |
| Volume | 1,282,500 | 1,241,150 | 3,520,725 | 1,095,100 | 2,566,800 |
| 20-Day Average Volume | 1,200,985 | 1,545,410 | 1,864,715 | 1,278,430 | 2,185,800 |
| Previous Close | 120.46 | 14.93 | 193.24 | 9.08 | 42.74 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 126.69 | 14.88 | 188.39 | 8.95 | 45.27 |
| 20-Day Raw Stochastic | 3.57% | 33.33% | 61.84% | 55.40% | 22.76% |
| 20-Day Relative Strength | 33.12% | 57.38% | 60.16% | 56.54% | 42.76% |
| Weighted Alpha | -5.91 | -0.77 | +12.39 | +29.97 | -4.37 |
| Today's Opinion | 40% Sell | 72% Buy | 88% Buy | 80% Buy | 40% Sell |
| Previous Opinion | 40% Sell | 88% Buy | 88% Buy | 88% Buy | 40% Sell |
| Last Month's Opinion | 100% Buy | 56% Buy | 56% Buy | 16% Buy | 64% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.19% since 09/13/24 | +0.68% since 09/13/24 | +0.81% since 09/13/24 | -3.35% since 09/13/24 | +1.35% since 09/13/24 |
| Low | 117.00 on 09/20/24 | 14.69 on 09/16/24 | 191.07 on 09/20/24 | 8.69 on 09/18/24 | 40.50 on 09/16/24 |
| High | 123.57 on 09/16/24 | 14.94 on 09/17/24 | 200.33 on 09/19/24 | 9.28 on 09/16/24 | 43.50 on 09/19/24 |
| 1-Month | |||||
| %Chg | -20.88% since 08/20/24 | +0.27% since 08/20/24 | +4.92% since 08/20/24 | +24.48% since 08/20/24 | -9.66% since 08/20/24 |
| Low | 117.00 on 09/20/24 | 14.66 on 09/13/24 | 180.18 on 08/23/24 | 7.54 on 08/21/24 | 40.50 on 09/16/24 |
| High | 154.87 on 08/23/24 | 15.08 on 08/23/24 | 200.33 on 09/19/24 | 9.57 on 08/29/24 | 50.43 on 08/30/24 |
| 3-Month | |||||
| %Chg | -11.73% since 06/20/24 | +17.37% since 06/20/24 | +14.54% since 06/20/24 | +28.22% since 06/20/24 | +4.78% since 06/20/24 |
| Low | 117.00 on 09/20/24 | 12.60 on 06/21/24 | 166.45 on 06/26/24 | 5.79 on 06/27/24 | 40.50 on 09/16/24 |
| High | 157.98 on 08/01/24 | 15.08 on 08/23/24 | 200.33 on 09/19/24 | 9.57 on 08/29/24 | 52.34 on 07/26/24 |
| 6-Month | |||||
| %Chg | -15.85% since 03/20/24 | +1.72% since 03/20/24 | +12.66% since 03/20/24 | +42.29% since 03/20/24 | -0.05% since 03/20/24 |
| Low | 117.00 on 09/20/24 | 12.57 on 06/20/24 | 144.80 on 04/22/24 | 5.79 on 06/27/24 | 35.95 on 05/31/24 |
| High | 157.98 on 08/01/24 | 15.08 on 08/23/24 | 200.33 on 09/19/24 | 9.57 on 08/29/24 | 52.34 on 07/26/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 12,122,732 | 47,251,016 | 88,174,448 | 6,243,045 | 6,238,545 |
| Shares Outstanding, K | 100,637 | 3,164,837 | 456,295 | 687,560 | 145,965 |
| Annual Sales | 1,887,100,000 | 29,419,960,000 | 8,544,000,000 | 7,134,500,000 | 787,650,000 |
| Annual Net Income | 249,700,000 | 994,060,000 | 2,344,000,000 | 64,200,000 | -366,290,000 |
| Last Quarter Sales | 590,200,000 | 7,731,140,000 | 2,361,000,000 | 1,957,700,000 | 225,250,000 |
| Last Quarter Net Income | 65,000,000 | 609,590,000 | 624,000,000 | 15,980,000 | -66,270,000 |
| 60-Month Beta | 0.37 | 0.54 | 0.88 | 0.50 | 0.39 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.63 on 08/01/24 | 0.56 on 07/31/24 | 1.56 on 08/06/24 | 0.02 on 07/30/24 | -0.45 on 08/01/24 |
| Latest Earnings Date | 10/29/24 | 10/24/24 | 11/07/24 | 08/01/24 | 11/07/24 |
| Most Recent Dividend | N/A | 0.261 on 09/28/23 | 0.432 on 07/18/24 | 0.370 on 06/03/21 | N/A |
| Next Ex-Dividends Date | N/A | 03/27/24 | 07/18/24 | 06/03/21 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 36.21 | 9.44 | 35.47 | 0.00 | 0.00 |